Report Overview

The global dermal fillers market was pegged at US$ 4.98 billion in 2021 and is expected to register a revenue CAGR of 7.10% during the forecast period. 

Market Fundamentals 

Dermal fillers are used as a restorative tool for the fixation of physical appearance and age-associated lines and wrinkles. Dermal fillers are used for restoring volume in the face, reducing the appearance of wrinkles, facial line correction, smile fixation, and scar treatment. Collagen provides structural support to tissues and gives elasticity and strength to the skin. Collagen is composed of hydroxyproline, proline, and acids glycine. It is found in skin, tendons, connective tissue, cartilage, and bone. With aging, the body stops producing collagen, and with it, the skin starts to lose its suppleness and flexibility. To reduce the visible signs of aging, dermal fillers play an important role as they fill the volume of the skin, make face lines more symmetrical, and plump up cheeks and lips.

[454545]

Market Dynamics

The global dermal fillers market revenue is mainly driven by the growing demand for aesthetic correction and restoration, and the growing influence of social media. Additionally, obsession with a youthful appearance, intensive research and development in dermatological fillers, introduction of novel fillers, and growing disposable incomes are also driving the market revenue growth for dermal fillers. However, the high cost of fillers, surgical limitations, risk of undesirable procedure outcomes, and increasing awareness about body positivity are restricting the global dermal fillers market revenue growth to some extent.

Market Ecosystem

The global dermal fillers market has been analyzed from five perspectives: types, materials, application, end user, and region. 

Dermal Fillers Market by Type

[67874543534]

Based on type, the global dermal fillers market has been segmented into temporary & semi-permanent, and permanent. The temporary dermal fillers are bioresorbable and last for 6 months to 1 year. The temporary and semi-permanent dermal fillers segment holds the largest share during the forecast period owing to its low cost, easy procedure, minimum-invasive procedure, easily removable, and body compatibility. Additionally, the introduction of novel products, technological advancement, and demand for aesthetic procedures are also expected to contribute to market revenue growth.

Dermal Fillers Market by Materials

Based on materials, the global dermal fillers market is segmented into bovine collagen, porcine collagen, fat fillers, hyaluronic acid, poly-l-lactic acid, calcium hydroxyapatite, polymethyl methacrylate, and polyacrylamide gels. Hyaluronic acid is leading the global dermal filler market owing to its efficiency in treating wrinkles and facial lines, skin tightening, hydration & moisturization, stimulating regeneration of skin cells, and repairing dermal discoloration. Additionally, its low cost, minimally invasive procedures, and the introduction of novel products are also contributing to the revenue growth of the hyaluronic acid global market. Moreover, the future for hyaluronic acid dermal fillers is quite promising owing to continuous research & development and emerging biotechnology.

Dermal Fillers Market by Application

Based on application, the global dermal fillers market has been segmented into lip enhancement, nose reshaping, facelift, facial line correction, wrinkle correction, and scar treatment. Nose reshaping, also known as rhinoplasty, helps to improve the nose’s appearance aesthetically or repair it for clinical implications. Nose reshaping procedures have the highest market revenue share attributed to increasing aesthetical demand for nose reshaping, the growing prevalence of nasal deformities, and increasing cases of nasal obstruction. Additionally, low-cost procedures as compared to other cosmetic procedures, and less recovery time are also contributing to the global dermal fillers market revenue growth. For instance, according to the American Society of Plastic Surgeons, in 2020, around 2,314,720 cosmetic surgeries were performed in the US, out of which, 352,555 were nose reshaping.

Dermal Fillers Market by End User

Based on end user, the global dermal fillers market has been segmented into hospitals and clinics, dermatology clinics, and cosmetic centers. Cosmetic centers demonstrate the fastest market revenue growth owing to increasing demand for aesthetic procedures i.e., wrinkle fixation, nose reshaping, smile correction, face lifting, lips lifting, and eyelid surgery. Additionally growing geriatric population, technological advancement, increasing awareness about cosmetic surgery, and increasing footfall of patients to cosmetic centers are also contributing to the global dermal fillers market revenue growth.

Dermal Fillers Market by Region

Based on region, the global dermal fillers market has been segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America dominated the global dermal fillers market, followed by the Asia Pacific. The large revenue share of North America in the global market can be attributed to the high disposable income, the growing geriatric population, the high demand for both invasive and non-invasive aesthetic procedures, and the availability of skilled cosmetic surgeons. Additionally, technological advancement, developed infrastructure, and the high number of approved dermal fillers are also contributing to the revenue growth of the North American dermal fillers market. The Asia Pacific region is also expected to register exponential revenue growth owing to, its large population, increasing awareness, developing infrastructure, and emerging biotechnology & pharmaceutical market. Additionally, growing regional market players, untapped opportunities, increased penetration of social media, and growing disposable incomes are also contributing to the market revenue growth.

Competitive Landscape

Some of the prominent players operating in the dermal fillers market are: 

• Galderma SA
• Sinclair Pharma
• Bioxis Pharmaceuticals
• SCULPT Luxury Dermal Fillers Ltd
• DR. Korman Laboratories
• Prollenium Medical Technologies Inc.
• Suneva Medical
• BioPlus Co., Ltd.
• Anika Therapeutics, Inc.
• Allergan (AbbVie, Inc.)
• Revance Therapeutics, Inc. 
• Merz GmbH & Co. KGaA

Strategic Developments

• In Feb 2022, Allergan Aesthetics, an AbbVie company received Food and Drug Administration approval for Juvederm Volbella XC for Under Eye Filler and improvement for patients over the age of 21.
• In May 2022, Galderma presented its extensive new portfolio of neuromodulators, fillers, biostimulators, and clinical data at the IMCAS World Congress 2022
• In Sep 2021, Galderma announced a partnership with Sofregen Medical Inc to develop next-generation fillers. This partnership will utilize the power of silk protein for immediate volume restoration and provide structure for tissue Strengthening.
• In Sept 2019, Allergan received the U.S. Food and Drug Administration approval for the use of Juvederm VOLUMA XC hyaluronic acid gel dermal filler to correct the age-related deficit.

Frequently Asked Questions About This Report